> About Us
> Advisory Team
Elsa Chi Abruzzo
Elsa has more than 20 years of regulatory, clinical, and quality engineering experience with medical devices and disruptive biotechnologies, including surgical and transcatheter tissue heart valves, embolic agents, stents, surgical adhesives, and biomaterials. She has worked for companies such as Baxter, Cordis Johnson and Johnson, CryoLife, Percutaneous Valve Technologies, and AtriCure. Elsa's global clinical and regulatory strategies have resulted in the successful commercialization of products in the USA and worldwide. Elsa has a B.S. in Engineering from the University of Miami (Coral Gables, FL), is regulatory affairs certified (RAC), and a Regulatory Affairs Professional Society (RAPS) Fellow (2010).
Mr. Davis is a seasoned medical device executive with global experience in finance, manufacturing, sales and general management. He joined Tryton Medical in 2008 as the President and CEO where he raised $20 million in Series D financing and launched the company’s Side Branch Stent across Europe. Prior to joining Tryton, Mr. Davis was president of Guidant Japan responsible for the company’s $225 million cardiovascular business. Prior to his work in Japan, Mr. Davis managed Guidant’s product portfolio in 13 Asian countries. Mr. Davis started his career in various financial management roles with Cardiac Pacemakers Incorporated and Eli Lilly in the U.S. and Puerto Rico. Mr. Davis holds a B.S. in mechanical engineering from the University of Minnesota and an M.B.A. from the University of Michigan. Mr. Davis is the Chairman of the Board for ibiliti.